Education
About Us
Working with TipRanks
Follow Us
Bioxyne Limited (AU:BXN)
ASX:BXN
Total Valuation
Bioxyne Limited has a market cap or net worth of AU$91.22M. The enterprise value is AU$86.43M.
Market CapAU$91.22M
Enterprise ValueAU$86.43M
Share Statistics
Bioxyne Limited has 2,171,828,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,171,828,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioxyne Limited’s return on equity (ROE) is 0.42 and return on invested capital (ROIC) is 50.46%.
Return on Equity (ROE)0.42
Return on Assets (ROA)0.23
Return on Invested Capital (ROIC)50.46%
Return on Capital Employed (ROCE)0.45
Revenue Per Employee1.90M
Profits Per Employee306.32K
Employee Count16
Asset Turnover1.46
Inventory Turnover4.88
Valuation Ratios
The current PE Ratio of Bioxyne Limited is 17.5. Bioxyne Limited’s PEG ratio is -0.13.
PE Ratio17.5
PS Ratio2.90
PB Ratio7.54
Price to Fair Value7.54
Price to FCF22.82
Price to Operating Cash Flow14.74
PEG Ratio-0.13
Income Statement
In the last 12 months, Bioxyne Limited had revenue of 30.42M and earned 4.90M in profits. Earnings per share was 0.00.
Revenue30.42M
Gross Profit10.45M
Operating Income5.56M
Pretax Income4.90M
Net Income4.90M
EBITDA5.34M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 6.28M and capital expenditures -2.41M, giving a free cash flow of 3.86M billion.
Operating Cash Flow6.28M
Free Cash Flow3.86M
Free Cash Flow per Share<0.01
Dividends & Yields
Bioxyne Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.16
52-Week Price Change300.00%
50-Day Moving Average0.04
200-Day Moving Average0.04
Relative Strength Index (RSI)48.68
Average Volume (3m)4.35M
Important Dates
Bioxyne Limited upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend Date―
Financial Position
Bioxyne Limited as a current ratio of 2.03, with Debt / Equity ratio of 13.13%
Current Ratio2.03
Quick Ratio1.54
Debt to Market Cap<0.01
Net Debt to EBITDA-1.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bioxyne Limited has paid -840.05K in taxes.
Income Tax-840.05K
Effective Tax Rate-0.17
Enterprise Valuation
Bioxyne Limited EV to EBITDA ratio is 15.35, with an EV/FCF ratio of 21.23.
EV to Sales2.70
EV to EBITDA15.35
EV to Free Cash Flow21.23
EV to Operating Cash Flow13.06
Balance Sheet
Bioxyne Limited has AU$7.67M in cash and marketable securities with AU$1.53M in debt, giving a net cash position of AU$6.13M billion.
Cash & Marketable SecuritiesAU$7.67M
Total DebtAU$1.53M
Net CashAU$6.13M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 34.35%, with operating margin of 18.28%, and net profit margin of 16.11%.
Gross Margin34.35%
Operating Margin18.28%
Pretax Margin16.11%
Net Profit Margin16.11%
EBITDA Margin17.56%
EBIT Margin16.76%
Analyst Forecast
The average price target for Bioxyne Limited is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast204.87%
EPS Growth Forecast―